Stent Prices

The National Pharmaceutical Pricing Authority (NPPA) invoked the para 32 (ii) of the Drug Price Control Order, 2013 to grant the exemption to the indigenously developed stent

According to industry estimates in 2018 calendar year the overall Indian cardiac stent market grew by 16-18 per cent in terms of volumes

Price control on stents should have been thought through

NPPA has also fixed ceiling price of 46 drug formulations used for various ailments